As a consumer health category, sleep aids is still relatively small, despite the apparent magnitude of sleep issues among Australians. Therefore, it offers significant room for growth in the local market, with more adults expected to experience some kind of sleep problem in the coming years and an increasing number searching for solutions to help them sleep, as lack of sleep can affect their overall wellbeing and ability to perform their job properly.
In November 2023, the Australian Senate referred an inquiry into the issues related to menopause and perimenopause to the Senate Community Affairs References Committee, with the report due in September 2024. The inquiry has thus far heard that Australian women undergoing menopause and perimenopause are being held back from their full potential, as they are not finding adequate support for their health needs from medical professionals.
Retailers of consumer health products are currently awaiting the decision from the Australian Competition and Consumer Commission (ACCC) as to whether it will approve the proposed merger of Chemist Warehouse and Sigma Healthcare, which would considerably impact OTC sales in Australia. Proposed in December 2023, the deal would introduce Chemist Warehouse to a public listing on the Australian Securities Exchange (ASX) through Sigma, and potentially span a huge network of 864 outlets under the Chemist Warehouse, MyChemist, Amcal and Discount Drug Stores brands, in addition to a large wholesale business.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Sleep Aids industry in Australia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Sleep Aids industry in Australia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
These aids include combinations of active ingredients (e.g. diphenhydramine + acetaminophen) and single ingredient (e.g. doxylamine succinate). Herbal remedies made with valerian root, passionflower, and others, are included. This category also tracks melatonin products - a hormone, even if they are classified as a dietary supplement in some countries.
See all of our definitionsThis report originates from Passport, our Sleep Aids research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!